| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |